Interv Akut Kardiol. 2019;18(2):96-98 | DOI: 10.36290/kar.2019.026

Treatment with beta blockers in myocardial infarction in the era of primary PCI

Petr Janský
Klinika kardiovaskulární chirurgie 2. LF UK a FN v Motole, Praha

Treatment with beta blockers has for several decades been the mainstay of secondary prevention after a recent myocardial infarction.
Studies that showed a favourable prognostic effect of beta blockers were carried out in a period prior to the routine use of reperfusion
treatment. In patients treated with fibrinolytic therapy, the benefit is less pronounced. Even less clear is the situation in patients who
are treated with primary percutaneous coronary intervention, since previous prospective studies as well as observational data from
registries have so far failed to provide an unequivocal opinion as to the indications and clinical benefit of beta blockers.

Keywords: beta blockers, myocardial infarction, secondary prevention, primary PCI

Published: May 2, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janský P. Treatment with beta blockers in myocardial infarction in the era of primary PCI. Interv Akut Kardiol. 2019;18(2):96-98. doi: 10.36290/kar.2019.026.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Freemantle N, Cleland J, Young P, et al. Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 1999; 318(7200): 1730-1737. Go to original source... Go to PubMed...
    2. Dargie HJ, et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. The Lancet 2001. 357(9266): 1385-1390. Go to original source... Go to PubMed...
    3. Chen ZM, et al. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial. The Lancet 2005; 366(9497): 1622-1632. Go to original source... Go to PubMed...
    4. Bangalore S, Makani H, Radford M, et al. Clinical outcomes with ?-blockers for myocardial infarction: a meta-analysis of randomized trials. Am J Med. 2014; 127(10): 939-953. Go to original source... Go to PubMed...
    5. Hanada K, Higuma T, Nishizaki F, et al. Randomized study on the efficacy and safety of landiolol, an ultra-short-acting ?1-adrenergic blocker, in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ J. 2012; 76(2): 439-445. Go to original source... Go to PubMed...
    6. Ibanez B, Macaya C, Sánchez-Brunete V, et al. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial. Circulation 2013; 128(14): 1495-1503. Go to original source... Go to PubMed...
    7. Pizarro G, Fernández-Friera L, Fuster V, et al. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction). J Am Coll Cardiol. 2014; 63(22): 2356-2362. Go to original source... Go to PubMed...
    8. Roolvink V, Ibá?ez B, Ottervanger JP, et al. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention. J Am Coll Cardiol. 2016; 67(23): 2705-2715. Go to original source... Go to PubMed...
    9. Er F, Dahlem KM, Nia AM, et al. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial. JACC Cardiovasc Interv. 2016; 9(3): 231-240. Go to original source... Go to PubMed...
    10. Elgendy IY, Elgendy AY, Mahmoud AN, et al. Intravenous ?-blockers for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials. Int J Cardiol. 2016; 223: 891-897. Go to original source... Go to PubMed...
    11. Bangalore S, Steg G, Deedwania P, et al. ?-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease. JAMA. 2012; 308(13): 1340-1349. Go to original source... Go to PubMed...
    12. Bauters C, Lemesle G, Meurice T, et al. Prognostic impact of ß-blocker use in patients with stable coronary artery disease. Heart. 2014; 100(22): 1757-1761. Go to original source... Go to PubMed...
    13. Goldberger JJ, Bonow RO, Cuffe M, et al. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction. J Am Coll Cardiol. 2015; 66(13): 1431-1441. Go to original source... Go to PubMed...
    14. Yang JH, Hahn JY, Song YB, et al. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. JACC Cardiovasc Interv. 2014; 7(6): 592-601. Go to original source... Go to PubMed...
    15. Raposeiras-Roubin S, Abu-Assi E, Caneiro-Queija B, et al. Effect of beta-blocker dose on mortality after acute coronary syndrome. Rev Port Cardiol. 2018; 37(3): 239-245. Go to original source... Go to PubMed...
    16. Huang BT, Huang FY, Zuo ZL, et al. Meta-Analysis of Relation Between Oral ?-Blocker Therapy and Outcomes in Patients With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention. Am J Cardiol. 2015; 115(11): 1529-1538. Go to original source... Go to PubMed...
    17. Magnus Dahl A, Sandven I, Dondo TB, et al. Effect of oral ?-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother. 2019; 5(1): 12-20. Go to original source... Go to PubMed...
    18. Dondo TB, Hall M, West RM, et al. ?-Blockers and Mortality After Acute Myocardial Infarction in Patients Without Heart Failure or Ventricular Dysfunction. J Am Coll Cardiol. 2017; 69(22): 2710-2720. Go to original source... Go to PubMed...
    19. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting withST-segment elevation. European Heart Journal 2018; 39: 119-177. Go to original source... Go to PubMed...

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.